The in vitro AChE and BuChE inhibition potentials of newly synthesized oxadiazole derivatives were assessed by comparing their half maximum inhibitory concentration (IC50) values to those of anti-AD drugs, donepezil and rivastigmine. The gene discussed is ACHE; the disease is Alzheimer disease.